Grimaud Brett A. (CIK 1966698) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-22). Recent activity: Sell TBPH (8,829 shares), Buy TBPH (37,500 shares), Sell TBPH (20,833 shares), Sell TBPH (19,024 shares), Sell TBPH (9,762 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 8,829 | $146,120 |
| 2026-04-03 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Buy | 37,500 | $0 |
| 2026-02-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 20,833 | $409,577 |
| 2025-11-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 19,024 | $340,530 |
| 2025-08-22 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 9,762 | $130,713 |
| 2025-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 9,743 | $92,071 |
| 2025-03-04 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Buy | 75,000 | $0 |
| 2025-02-24 | Theravance Biopharma, Inc. (TBPH) | SVP, GEN COUNSEL AND SECRETARY | Sell | 14,534 | $140,398 |
Source: SEC Form 4 filings · as of 2026-05-22